Cepheid Company Profile (NASDAQ:CPHD)

Analyst Ratings

Consensus Ratings for Cepheid (NASDAQ:CPHD) (?)
Ratings Breakdown: 9 Hold Rating(s), 12 Buy Rating(s)
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $40.13 (13.59% upside)

Analysts' Ratings History for Cepheid (NASDAQ:CPHD)
Show:
DateFirmActionRatingPrice TargetActions
7/29/2016JPMorgan Chase & Co.Boost Price TargetNeutral$32.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2016Canaccord GenuityReiterated RatingHold$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016Morgan StanleyInitiated CoverageEqual Weight$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016Needham & Company LLCReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016Atlantic SecuritiesUpgradeNeutral -> OverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016BTIG ResearchUpgradeNeutral -> Buy$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016WedbushLower Price TargetOutperform$58.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Robert W. BairdLower Price TargetOutperform$45.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Stifel NicolausLower Price TargetBuy$42.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Barclays PLCLower Price TargetEqual Weight$38.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Leerink SwannReiterated RatingMarket Perform$39.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2016Avondale PartnersInitiated CoverageOutperform$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2015Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Craig HallumLower Price TargetBuy$52.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Evercore ISIUpgradeSell -> Hold$44.50 -> $32.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015MizuhoLower Price TargetBuy$60.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2015Citigroup Inc.Lower Price TargetBuy$62.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015Piper Jaffray Cos.Reiterated RatingBuy$66.00 -> $62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015Jefferies GroupLower Price TargetHold$55.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015Goldman Sachs Group Inc.Lower Price Target$53.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2015MKM PartnersReiterated RatingBuy$65.00 -> $72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Evercore Partners Inc.Reiterated RatingHold -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2015Cantor FitzgeraldReiterated RatingBuy$62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015JMP SecuritiesBoost Price TargetMarket Outperform$58.00 -> $67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2015Oppenheimer Holdings Inc.Boost Price TargetOutperform$57.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2014William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2014Bank of America Corp.UpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2014S&P Equity ResearchBoost Price TargetAverage -> Hold$6.58 -> $8.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Cepheid (NASDAQ:CPHD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
7/28/2016Q216($0.14)$0.05$145.82 million$146.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2016Q116$0.01$0.08$140.35 million$144.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/2/2016Q415($0.20)$0.07$146.95 million$147.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/20/2015Q3($0.31)($0.13)$126.81 million$126.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2015Q215($0.21)($0.06)$130.70 million$132.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2015Q115($0.16)$0.01$125.50 million$132.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2015Q414($0.13)$0.11$125.34 million$131.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/16/2014Q314($0.16)$0.06$110.10 million$115.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/17/2014Q214($0.13)$0.03$115.47 million$116.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/17/2014Q114($0.17)($0.01)$104.90 million$106.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014Q413($0.11)($0.15)$102.17 million$113.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/17/2013Q313($0.11)($0.20)$93.70 million$100.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/18/2013Q2 2013$0.04$0.02$92.57 million$96.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/18/2013Q1 2013$0.10$0.11$89.12 million$91.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/24/2013Q4 2012$0.11$0.20$92.87 million$92.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/18/2012($0.07)($0.32)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/19/2012$0.11$0.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/19/2012($0.01)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/26/2012($0.02)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/20/2011$0.02$0.03ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/21/2011($0.01)$0.03ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/20/2011($0.01)$0.01ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2011($0.02)$0.02ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cepheid (NASDAQ:CPHD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.26)($0.16)($0.21)
Q2 20163($0.20)($0.17)($0.18)
Q3 20163($0.18)($0.11)($0.15)
Q4 20162($0.03)($0.01)($0.02)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cepheid (NASDAQ:CPHD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cepheid (NASDAQ:CPHD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/3/2016Scott A CampbellVPSell2,058$27.90$57,418.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Peter V FarrellEVPSell390$28.90$11,271.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2016Peter V FarrellEVPSell390$36.30$14,157.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/25/2016John L BishopCEOSell110,000$35.50$3,905,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016Peter V FarrellEVPSell393$33.01$12,972.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/8/2016Warren C. Kocmond, Jr.COOSell292$28.53$8,330.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2016Warren C. Kocmond, Jr.COOSell351$28.44$9,982.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2016Warren C. Kocmond, Jr.COOSell157$33.16$5,206.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2015Peter V. FarrellEVPSell394$31.67$12,477.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2015Robert J EastonDirectorSell3,206$36.02$115,480.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2015Robert J EastonDirectorSell2,724$34.84$94,904.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015Robert J EastonDirectorSell2,556$35.01$89,485.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2015Peter V. FarrellEVPSell1,560$33.89$52,868.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2015Peter V. FarrellEVPSell1,577$48.67$76,752.59View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2015Cristina KepnerDirectorBuy10,000$47.78$477,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2015Warren C Kocmond JrCOOSell9,375$61.52$576,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2015Thomas L GutshallDirectorSell1,800$56.62$101,916.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/21/2015Joseph H SmithEVPSell91,866$54.51$5,007,615.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015John L BishopCEOSell100,000$55.20$5,520,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2015Hollings RentonDirectorSell9,375$57.76$541,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015Dean O MortonDirectorSell12,500$58.51$731,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Thomas D BrownDirectorSell12,500$56.29$703,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/30/2015Andrew MillerCFOSell6,677$57.64$384,862.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Andrew MillerCFOSell11,719$56.65$663,881.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015David H PersingEVPSell5,000$56.90$284,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Warren C Kocmond JrCOOSell4,688$57.00$267,216.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Andrew MillerCFOSell2,250$54.95$123,637.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Kerry FlomEVPSell8,694$54.21$471,301.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2014Dean O MortonDirectorSell11,849$52.96$627,523.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2014Hollings RentonDirectorSell9,375$51.07$478,781.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Andrew MillerCFOSell12,167$53.84$655,071.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014David H PersingEVPSell20,000$53.34$1,066,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Dean O MortonDirectorSell7,500$52.64$394,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2014Kerry FlomEVPSell7,077$51.36$363,474.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2014Thomas L GutshallDirectorSell12,500$51.63$645,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014David H PersingEVPSell15,000$51.51$772,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014Kerry FlomEVPSell1,271$44.52$56,584.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Warren C Kocmond JrEVPSell324$38.69$12,535.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2014Kerry FlomEVPSell2,812$49.72$139,812.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/3/2014Kerry FlomEVPSell1,282$48.97$62,779.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2014Kerry FlomEVPSell4,265$45.49$194,014.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2014Warren C Kocmond JrEVPSell1,300$42.38$55,094.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2014Kerry FlomEVPSell2,660$42.38$112,730.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/25/2014John BishopCEOSell107,651$43.93$4,729,108.43View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/22/2014John BishopCEOSell42,349$46.11$1,952,712.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/22/2014Robert EastonDirectorSell12,500$45.59$569,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/3/2014Kerry FlomEVPSell1,621$51.55$83,562.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2014Andrew MillerCFOSell4,688$52.78$247,432.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2014Andrew MillerCFOSell17,265$55.55$959,070.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2014Andrew MillerCFOSell63,375$53.10$3,365,212.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2014John BishopCEOSell150,000$50.67$7,600,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2014Joseph SmithEVPSell50,000$51.15$2,557,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/3/2014Kerry FlomEVPSell6,357$45.66$290,260.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Andrew MillerCFOSell2,437$45.92$111,907.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/23/2013Kerry FlomEVPSell10,000$46.51$465,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2013David H PersingVPSell5,000$41.35$206,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Kerry FlomEVPSell2,660$40.50$107,730.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2013Thomas L GutshallDirectorSell3,000$40.07$120,210.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/18/2013David H PersingVPSell20,000$40.59$811,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/24/2013Thomas GutshallDirectorSell3,000$38.97$116,910.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013David PersingVPSell5,000$39.34$196,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013David PersingVPSell5,000$38.95$194,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/6/2013David H PersingVPSell20,000$37.99$759,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013David PersingVPSell5,129$36.62$187,823.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Thomas GutshallDirectorSell3,000$36.38$109,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2013Robert EastonDirectorSell7,500$35.01$262,575.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/24/2013Thomas L GutshallDirectorSell3,000$34.18$102,540.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2013Thomas L GutshallDirectorSell3,000$32.91$98,730.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Andrew MillerCFOSell22,468$38.51$865,242.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2013Thomas L GutshallDirectorSell3,000$37.90$113,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Kerry FlomEVPSell6,832$39.76$271,640.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2013Thomas L GutshallDirectorSell3,000$38.28$114,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2013Joseph H SmithEVPSell38,400$36.20$1,390,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/24/2012Thomas L GutshallDirectorSell3,000$33.06$99,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2012Thomas L GutshallDirectorSell7,778$31.94$248,429.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cepheid (NASDAQ:CPHD)
DateHeadline
07/29/16 08:48 PMCEPHEID (CPHD) Jumps 8.04% on July 29 - Equities.com
07/29/16 03:28 PMMorgan Stanley Starts Coverage on CEPHEID (CPHD) With An Initial Rating Of "Equal-weight" - Finance Daily
07/29/16 03:28 PMCepheid's (CPHD) Q2 Loss Narrower than Estimate, View Up - Nasdaq
07/29/16 02:09 PMCepheid's (CPHD) Q2 Loss Narrower than Estimate, View Up -
07/29/16 07:14 AMCepheid (CPHD) John L. Bishop on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha
07/28/16 08:00 PMEdited Transcript of CPHD earnings conference call or presentation 28-Jul-16 9:00pm GMT -
07/28/16 05:37 PMCepheid reports 2Q loss - [AP] - The Sunnyvale, California-based company said it had a loss of 14 cents per share. Earnings, adjusted for stock option expense and amortization costs, came to 5 cents per share. The results exceeded Wall ...
07/28/16 04:28 PMCepheid (CPHD) Reports Q2 EPS of $0.05 - StreetInsider.com
07/28/16 04:00 PMCepheid Earnings Call scheduled for 5:00 pm ET today -
07/28/16 06:07 AMQ2 2016 Cepheid Earnings Release - After Market Close -
07/25/16 08:08 PMIt's Earnings Time: What to Do with Cepheid (NASDAQ:CPHD) Stock - The Voice Registrar
07/21/16 03:27 PMCEPHEID (NASDAQ:CPHD) Updated Price Targets - FTSE News
07/20/16 10:17 AMTechnical Notes on Scientific & Technical Instruments' Stocks -- Trimble Navigation, Garmin, Keysight Technologies, and Cepheid
07/18/16 03:35 PMShares of CEPHEID (CPHD) Drops by -1.89% - Trade Calls
07/12/16 07:23 AMCepheid Announces Results Of Validation Study For Use Of Xpert HPV In Primary Cervical Cancer Screening - [at noodls] - SUNNYVALE, Calif., July 12, 2016 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced the publication of a validation study assessing the use of Xpert HPV (Human Papillomavirus) as a front-line cervical ...
07/09/16 04:59 AMCEPHEID (CPHD) Jumps 6.47% on July 08 - Equities.com
07/09/16 04:59 AMCepheid (CPHD) Shares Cross Above 200 DMA - Nasdaq
07/08/16 08:25 PMCepheid (CPHD) Shares Cross Above 200 DMA
07/08/16 03:25 PMShares of CEPHEID (CPHD) Sees Large Outflow of Money - TheFounders Daily
07/07/16 03:24 PMCEPHEID (CPHD) : Analyst Rating Update - Trade Calls
07/07/16 03:11 PMCepheid Schedules 2016 Second Quarter Results Announcement And Webcast - [at noodls] - SUNNYVALE, Calif., July 7, 2016 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2016 second quarter on Thursday, July 28, 2016, after the close of the ...
07/06/16 09:11 PMCEPHEID (CPHD) Jumps 7.94% on July 04 - Equities.com
07/06/16 11:19 AMThese 2 Undervalued Health Care Stocks Are Poised to Break Higher - [at TheStreet] - Shares of Cepheid and Hologic are oversold and are on their way up.
07/05/16 08:00 AMOpening Of Hammersmith Clinic Furthers The Revolution In Sexual Health Diagnostic Services - [PR Newswire] - SUNNYVALE, Calif., July 5, 2016 /PRNewswire/ -- Cepheid (CPHD) today applauded the opening of the 10 Hammersmith Broadway Sexual Health clinic in London, England. The Hammersmith Clinic is the next in a series of new clinics developed by the Chelsea & Westminster NHS Foundation Trust. This is the same team behind the Dean Street Express, a highly acclaimed sexual health clinic located in London's Soho district that has been challenging the model for sexually transmitted infection (STI) testing and public health since it opened its doors in February 2014. 10 Hammersmith Broadway and Dean Street Express offer drop-in service and high throughput testing on site for a number of STIs, including CT/NG, HIV, and syphilis.
07/03/16 07:58 AMShare Performance Recap for: Cepheid (NASDAQ:CPHD) - Press Telegraph
07/03/16 07:58 AMAnalysts Ranking Previews: Linear Technology Corporation (NASDAQ:LLTC) , CEPHEID (NASDAQ:CPHD) - Street Updates
07/03/16 07:58 AMCEPHEID (CPHD) Jumps 7.94% on July 01 - Equities.com
07/01/16 03:24 PMStocks Post Modest Gains To Extend Winning Streak To Four Days - U.S. Commentary
07/01/16 10:36 AMFDA Supports Expanded Claims for Xpert Carba-R Test for "Superbugs"
06/30/16 03:36 PMCepheid (CPHD) Receives FDA Clearance for Expanded Xpert Carba-R Claims - StreetInsider.com
06/30/16 10:27 AMIn Another SunEdison Departure, CFO Designee Ilan Daskal Resigns
06/30/16 10:27 AMCepheid : FDA Supports Expanded Claims for Xpert Carba-R Test for "Superbugs"
06/30/16 10:27 AMFDA OKs Cepheid's rapid test for genetic markers of drug-resistant bacteria
06/28/16 08:13 AMCepheid (CPHD): New Tests Drive Growth, Competition Rife - Nasdaq
06/27/16 07:54 AMCepheid (CPHD): New Tests Drive Growth, Competition Rife
06/25/16 07:14 AMResMed (RMD), St. Jude (STJ), Cepheid (CPHD) Among Med Tech Companies with Most EU Exposure - Needham ... - StreetInsider.com
06/23/16 08:48 PMNew Broker Ratings For CEPHEID (NASDAQ:CPHD) - FTSE News
06/22/16 08:04 AMRecently Issued Stock Ratings For CEPHEID (NASDAQ:CPHD) - Fiscal Standard
06/21/16 07:08 AMCepheid breached its 50 day moving average in a Bullish Manner : CPHD-US : June 21, 2016 -
06/20/16 09:41 AMStock Buzz: Cepheid (NASDAQ:CPHD) - iStreetWire
06/18/16 03:08 PMShares of CEPHEID (NASDAQ:CPHD) Sees Large Outflow of Money - Trade Calls
06/18/16 07:58 AMHealthcare ratings roundup - new coverage
06/17/16 10:47 AMUpcoming Earnings Report: Cepheid (NASDAQ:CPHD) - iStreetWire
06/16/16 03:21 PMCepheid Margin Expansion Unlikely To Morgan Stanley, Stays On Sidelines
06/16/16 07:45 AMMorgan Stanley Begins Coverage on CEPHEID (CPHD) Giving It An Initial Rating Of "Equal-weight" - Finance Daily
06/15/16 08:07 AMMorgan Stanley Begins Coverage on CEPHEID (CPHD) Giving It An Initial Rating Of “Equal-weight”
06/15/16 07:49 AMCepheid Announces World Health Organization Prequalification Of Xpert HIV-1 Qualitative Test - [at noodls] - SUNNYVALE, Calif., June 15, 2016 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that its Xpert® HIV-1 Qual (Qualitative) test has been awarded World Health Organization (WHO) prequalification, ...
06/15/16 07:32 AM8:32 am Cepheid's Xpert HIV-1 Qual (Qualitative) test has received World Health Organization prequalification -
06/10/16 09:21 PMWhy Investors Love These Scientific & Technical Instruments' Stocks? - Trimble Navigation, Garmin, Cepheid, and Keysight Technologies
06/09/16 09:22 PMCEPHEID (NASDAQ:CPHD) Low Price Is Set At $28 - RealistInvestor.com

Social

About Cepheid

Cepheid logoCepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Scientific & Technical Instruments
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: CPHD
  • CUSIP: 15670R10
Key Metrics:
  • Previous Close: $35.33
  • 50 Day Moving Average: $31.31
  • 200 Day Moving Average: $30.91
  • P/E Ratio: N/A
  • P/E Growth: 6.54
  • Market Cap: $2.58B
  • Beta: 0.33
  • Current Year EPS Consensus Estimate: $-0.32 EPS
  • Next Year EPS Consensus Estimate: $0.5 EPS
Additional Links:
Cepheid (NASDAQ:CPHD) Chart for Saturday, July, 30, 2016